GeneDx Holdings (WGS) Reports Q4 results; offers guidance

GeneDx Holdings (NASDAQ: WGS) reported Q4 Revenue for the quarter at $95.3 million versus the consensus estimate of $61.7 million.

GUIDANCE:

GeneDx Holdings sees FY2025 revenue of $350-360 million, versus the consensus of $338.8 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i
• Texas AG Paxton announces ongoing investigation into Carnival over data breach
• Check Point joins OpenAI cyber partner program to embed AI models